The 2011 USP <797> Compliance Study results have been published.  To read the full article click here

The largest and most comprehensive study of <797> compliance ever undertaken was completed in June of this year.  The 2011 USP <797> Compliance Study was led by sterile compounding experts Eric Kastango, RPh, MBA, FASHP, and Kate Douglass, MS, RN, APN,C, CRNI.  We believe that the information gathered and the insights developed in this Study will be very valuable to the industry and will go a long way to improving patient safety.

The 2011 USP <797> Compliance Study used a sophisticated web-based <797> Gap Analysis Tool which Eric and Kate developed and have been using for the last several years. This tool was made available at no charge to all study participants.  It should also be noted that ALL INDIVIDUAL FACILITY RESULTS ARE CONFIDENITAL - ONLY AGGREGATE DATA WAS USED IN THE STUDY REPORT.

In return for their participation, each participant received a highly-detailed Action Plan that was automatically generated based on answers to the survey.  This Action Plan provided documentation that can be used to begin or continue sterile compounding practice improvements at your location.

To participate in the 2012 USP <797> Compliance Study send an e-mail to This e-mail address is being protected from spambots. You need JavaScript enabled to view it  and you will be notified when the Study begins in May 2012.